Evidence map›Paper›PMID 42182849›Full record

ArticleOpen forum infectious diseases2026

The Last Mile: Understanding Barriers to Hepatitis C Virus Microelimination Among People with HIV in San Francisco, 2021-2024.

Grace C Haser, Melissa A Sanchez, Rachel Grinstein, Aminah Habib, Melissa M Ongpin, Sharon Pipkin, Arpi S Terzian, Annie F Luetkemeyer, Stephanie E Cohen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Grace C HaserDepartment of Medicine, University of California, SanFrancisco (UCSF), San Francisco, California, USA.ORCID https://orcid.org/0000-0002-8227-2557
Melissa A SanchezDepartment of Public Health, SanFrancisco Department of Public Health (SFDPH), San Francisco, California, USA.
Rachel GrinsteinDepartment of Public Health, SanFrancisco Department of Public Health (SFDPH), San Francisco, California, USA.
Aminah HabibDepartment of Public Health, SanFrancisco Department of Public Health (SFDPH), San Francisco, California, USA.ORCID https://orcid.org/0009-0003-7594-2975
Melissa M OngpinDepartment of Public Health, SanFrancisco Department of Public Health (SFDPH), San Francisco, California, USA.
Sharon PipkinDepartment of Public Health, SanFrancisco Department of Public Health (SFDPH), San Francisco, California, USA.
Arpi S TerzianDepartment of Public Health, SanFrancisco Department of Public Health (SFDPH), San Francisco, California, USA.ORCID https://orcid.org/0000-0001-8956-4010
Annie F LuetkemeyerDepartment of Medicine, University of California, SanFrancisco (UCSF), San Francisco, California, USA.ORCID https://orcid.org/0000-0003-0911-1578
Stephanie E CohenDepartment of Public Health, SanFrancisco Department of Public Health (SFDPH), San Francisco, California, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tracking hepatitis C virus (HCV) viremia in people with human immunodeficiency virus and identifying reasons for nontreatment can inform HCV microelimination efforts. We analyzed a retrospective cohort of coinfected patients in San Francisco and found high rates of HCV clearance and identified targets for intervention to close treatment gaps.

Indexed as

hepatitis CHIVpublic health

Identifiers

PMID42182849
PMCPMC13192415

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.